Acute back pain: Benefits and risks of current treatments

Current Medical Research and Opinion

Volumn 26, Issue 1, 2010, Pages 179-190

  McCarberg, Bill H ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

Acetaminophen; Acute back pain; Heat; NSAID; Opioid; Tramadol

Indexed keywords

ACECLOFENAC; AMITRIPTYLINE; BACLOFEN; CAPSAICIN; CARISOPRODOL; CYCLOOXYGENASE 2 INHIBITOR; DANTROLENE; DIAZEPAM; DICLOFENAC; DIFLUNISAL; IBUPROFEN; INDOMETACIN; KETOROLAC; LIDOCAINE; LORNOXICAM; LYSINE ACETYLSALICYLATE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; ORPHENADRINE; PARACETAMOL; PIROXICAM; PLACEBO; RUBEFACIENT; TENOXICAM; TIZANIDINE; TRAMADOL; UNINDEXED DRUG; VALDECOXIB;

ADDICTION; BACKACHE; CLINICAL EFFECTIVENESS; CONSTIPATION; DIZZINESS; DRUG CONTRAINDICATION; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; EDEMA; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEAT TREATMENT; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; LIVER TOXICITY; LOW BACK PAIN; NAUSEA; PRACTICE GUIDELINE; PRESCRIPTION; RESPIRATION DEPRESSION; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; SWEATING; TREATMENT PLANNING; VOMITING; ACUTE DISEASE; HYPERTHERMIC THERAPY; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BACK PAIN; HUMANS; HYPERTHERMIA, INDUCED; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 77649224778     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903451348     Document Type: Review

References (104)

1. Jayson MI. Acute back pain. Clin Med 2001;1:188-89
2. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56 (Pubitemid 37254686)
3. NINDS. Pain: hope through research. 2009. Available at: http://www.ninds. nih.gov [Last accessed 11 June 2009]
4. Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
5. Blount BW, Hart G, Ehreth JL. A description of the content of army family practice. J Am Board Fam Pract 1993;6:143-52
6. Raspe H, Hueppe A, Neuhauser H. Back pain, a communicable disease? Int J Epidemiol 2008;37:69-74 (Pubitemid 351228615)
7. Suka M, Yoshida K. Musculoskeletal pain in Japan: prevalence and interference with daily activities. Mod Rheumatol 2005;15:41-7 (Pubitemid 40298422)
8. United States Bone and Joint Decade. USBJD Condition Kit: Low Back Pain. Scope of the Disease. 2007. Available at: www.usbjd.org/patients-public/index. cfm [Last accessed 11 June 2009]
9. United States Bone and Joint Decade. The burden of musculoskeletal diseases. 2009. Available at: www.boneandjointburden.org [Last accessed 11 June 2009]
10. Wenig CM, Schmidt CO, Kohlmann T, et al. Costs of back pain in Germany. Eur J Pain 2009;13:280-6
11. Wynne-Jones G, Dunn KM, Main CJ. The impact of low back pain on work: a study in primary care consulters. Eur J Pain 2008;12:180-8 (Pubitemid 350186119)
12. Canadian Chiropractic Association. Survey of Canadian Adults: Back Pain. 2003. Available at: http://www.ccachiro.org/client/cca/cca.nsf/object/Back+Pain/ file/5360+back+pain.pdf [Last accessed 11 June 2009]
13. Walker BF, Muller R, Grant WD. Low back pain in Australian adults: the economic burden. Asia Pacific J Public Health 2003;15:79-87 (Pubitemid 38326437)
14. Licciardone JC. The epidemiology and medical management of low back pain during ambulatory medical care visits in the United States. Osteopath Med Prim Care 2008;2:11
15. Kaiser Permanente. Controlling presenteeism. A healthy and productive workforce is the solution. 2009. Available at: https://brokernet.kp.org/wps/wcm/ connect/a07c25804dea54bf5b9db7/TTHP-PresenteeismCA.pdf?MOD= AJPERES [Last accessed 6 June 2009]
16. AAOS. Aching backs impact cost, disability. 2009. Available at: http://www.aaos.org/news/aaosnow/jan0/research6.asp9 [Last accessed 29 May 2009]
17. Atlas SJ, Deyo RA. Evaluating and managing acute low back pain in the primary care setting. J Gen Intern Med. 2001;16:120-31 (Pubitemid 32183571)
18. Leboeuf-Yde C. Back pain - individual and genetic factors. J Electromyogr Kinesiol 2004;14:129-33 (Pubitemid 38169113)
19. Siemionow K, Steinmetz M, Bell G, et al. Identifying serious causes of back pain: cancer, infection, fracture. Cleve Clin J Med 2008;75:557-66
20. Klineberg E, Mazanec D, Orr D, et al. Masquerade: medical causes of back pain. Cleve Clin J Med 2007;74:905-13
21. Fritz J, Niemeyer T, Clasen S, et al. Management of chronic low back pain: rationales, principles, and targets of imaging-guided spinal injections. Radiographics 2007;27:1751-71
22. Mulholland RC. Scientific basis for the treatment of low back pain. Ann R Coll Surg Engl 2007;89:677-81 (Pubitemid 47577779)
23. Chou R, Huffman LH; American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:505-14 (Pubitemid 351664521)
24. Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-91 (Pubitemid 351688341)
25. Cherkin DC, Wheeler KJ, Barlow W, et al. Medication use for low back pain in primary care. Spine (Phila Pa 1976). 1998;23:607-14
26. Di Iorio D, Henley E, Doughty A. A survey of primary care physician practice patterns and adherence to acute low back problem guidelines. Arch Fam Med 2000;9:1015-21 (Pubitemid 32014694)
27. Webster BS, Courtney TK, Huang YH, et al. Physicians' initial management of acute low back pain versus evidence-based guidelines. Influence of sciatica. J Gen Intern Med 2005;20:1132-5 (Pubitemid 43110264)
28. Cherkin DC, MacCornack FA, Berg AO. Managing low back pain - a comparison of the beliefs and behaviors of family physicians and chiropractors. West J Med 1988;149:475-80
29. American Pain Society. Evidence Review of American Pain Society/American Academy of Pain Medicine Evidence Review for Evaluation and Management of Low Back Pain. 2009
30. Pray WS, Pray JJ. Topical devices and products for pain. 2003. Available at: http://www.medscape.com/viewarticle/448275 [Last accessed 23 May 2009]
31. Trowbridge CA, Draper DO, Feland JB, et al. Paraspinal musculature and skin temperature changes: comparing the Thermacare HeatWrap, the Johnson & Johnson Back Plaster, and the ABC Warme-Pflaster. J Orthop Sports Phys Ther 2004;34:549-58 (Pubitemid 39249515)
32. Draper DO, Trowbridge CA, Eggett DL. The ThermaCare Heatwrap increases paraspinal muscle temperature greater than the Icy Hot Patch and the Metholatum Patch. J Athletic Training 2003;38:S-44
33. Draper DO, Trowbridge CA. The ThermaCare Heatwrap increases skin and paraspinal muscle temperature greater than the Curaheat Patch. J Athletic Training 2004;39:S93
34. McCarberg B, O'Connor A. A new look at heat treatment for pain disorders, part 1. APS Bulletin. 2004;14: Available at: http://www.ampainsoc.org/pub/ bulletin/nov04/inno1.htm [Last accessed 2 May 2009]
35. Nadler SF, Weingand K, Kruse RJ. The physiologic basis and clinical applications of cryotherapy and thermotherapy for the pain practitioner. Pain Physician 2004;7:395-9 (Pubitemid 39206379)
36. Kettenmann B, Wille C, Lurie-Luke E, et al. Impact of continuous low level heatwrap therapy in acute low back pain patients: subjective and objective measurements. Clin J Pain 2007;23:663-8 (Pubitemid 47462172)
37. Lurie-Luke E, Neubauer G, Lindl C, et al. An exploratory workplace study to investigate the perceived value of continuous low-level heatwrap therapy in manual workers. Occup Med (Lond) 2003;53:173-8 (Pubitemid 36582383)
38. Mayer JM, Mooney V, Matheson LN, et al. Continuous low-level heat wrap therapy for the prevention and early phase treatment of delayed-onset muscle soreness of the low back: a randomized controlled trial. Arch Phys Med Rehabil 2006;87:1310-17 (Pubitemid 44470767)
39. Nadler SF, Steiner DJ, Petty SR, et al. Overnight use of continuous low-level heatwrap therapy for relief of low back pain. Arch Phys Med Rehabil 2003; 84:335-42 (Pubitemid 36297731)
40. Nadler SF, Steiner DJ, Erasala GN, et al. Continuous low-level heatwrap therapy for treating acute nonspecific low back pain. Arch Phys Med Rehabil 2003;84:329-34 (Pubitemid 36297730)
41. Nadler SF, Steiner DJ, Erasala GN, et al. Continuous low-level heat wrap therapy provides more efficacy than ibuprofen and acetaminophen for acute low back pain. Spine 2002;27:1012-27
42. Nuhr M, Hoerauf K, Bertalanffy A, et al. Active warming during emergency transport relieves acute low back pain. Spine 2004;29:1499-503 (Pubitemid 38943831)
43. Tao XG, Bernacki EJ. A randomized clinical trial of continuous low-level heat therapy for acute muscular low back pain in the workplace. J Occup Environ Med 2005;47:1298-306 (Pubitemid 41813039)
44. French SD, Cameron M, Walker BF, et al. A Cochrane review of superficial heat or cold for low back pain. Spine 2006;31:998-1006 (Pubitemid 43785931)
45. Steinmeyer J. Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res 2000;2:379-85 (Pubitemid 32223768)
46. Waikakul S, Danputipong P, Soparat K. Topical analgesics, indomethacin plaster and diclofenac emulgel for low back pain: a parallel study. J Med Assoc Thai 1996;79:486-90
47. Cummins TR, Sheets PL, Waxman SG. The roles of sodium channels in nociception: Implications for mechanisms of pain. Pain 2007;131:243-57 (Pubitemid 47374344)
48. Rosielle DA. Fast Fact and Concept #148: The lidocaine patch EPERC. 2006. Available at: http://www.eperc.mcw.edu/FastFactPDF/Concept%20148.PDF [Last accessed 17 May 2009]
49. Gimbel J, Linn R, Hale M, et al. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther 2005;12:311-19 (Pubitemid 41391809)
50. Mason L, Moore RA, Derry S, et al. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ 2004;328:991
51. Russell LC, Burchiel KJ. Neurophysiological effects of capsaicin. Brain Res 1984;320:165-76 (Pubitemid 15131089)
52. Morisset V, Ahluwalia J, Nagy I, et al. Possible mechanisms of cannabinoidinduced antinociception in the spinal cord. Eur J Pharmacol 2001; 429:93-100 (Pubitemid 33043985)
53. Ginsberg F, Famaey JP. A double-blind study of topical massage with Rado-Salil ointment in mechanical low-back pain. J Int Med Res 1987;15: 148-53 (Pubitemid 17096793)
54. Matthews P, Derry S, Moore RA, et al. Topical rubefacients for acute and chronic pain in adults. Cochrane Database Syst Rev 2009;CD007403
55. Aronoff DM, Oates JA, Boutaud O. New insights into the mechanism of action of acetaminophen: its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases. Clin Pharmacol Ther 2006;79:9-19 (Pubitemid 43069574)
56. Cabane J, Festino C, Lablache Combier B. Comparative trial of lysine acetylsalicylate and paracetamol on pain in daily medical practice. Presse Med 1996;25:1367-71
57. Stein D, Peri T, Edelstein E, et al. The efficacy of amitriptyline and acetaminophen in the management of acute low back pain. Psychosomatics 1996;37:63-70 (Pubitemid 26021822)
58. Davies RA, Maher CG, Hancock MJ. A systematic review of paracetamol for non-specific low back pain. Eur Spine J 2008;17:1423-30
59. Amlie E, Weber H, Holme I. Treatment of acute low-back pain with piroxicam: results of a double-blind placebo-controlled trial. Spine 1987;12:473-6 (Pubitemid 17108347)
60. Berry H, Hutchinson DR. Tizanidine and ibuprofen in acute low-back pain: results of a double-blind multicentre study in general practice. J Int Med Res 1988;16:83-91
61. Borenstein DG, Lacks S, Wiesel SW. Cyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasm. Clin Ther 1990;12:125-31 (Pubitemid 20176184)
62. Dreiser RL, Marty M, Ionescu E, et al. Relief of acute low back pain with diclofenac-K 12.5 mg tablets: a flexible dose, ibuprofen 200 mg and placebo-controlled clinical trial. Int J Clin Pharmacol Ther 2003;41:375-85 (Pubitemid 37121171)
63. Orava S. Medical treatment of acute low back pain. Diflunisal compared with indomethacin in acute lumbago. Int J Clin Pharmacol Res 1986;6:45-51 (Pubitemid 16130725)
64. Innes GD, Croskerry P, Worthington J, et al. Ketorolac versus acetaminophen- codeine in the emergency department treatment of acute low back pain. J Emerg Med 1998;16:549-56 (Pubitemid 28348161)
65. Pohjolainen T, Jekunen A, Autio L, et al. Treatment of acute low back pain with the COX-2-selective anti-inflammatory drug nimesulide: results of a randomized, double-blind comparative trial versus ibuprofen. Spine 2000;25: 1579-85 (Pubitemid 30418474)
66. Schattenkirchner M, Milachowski KA. A double-blind, multicentre, randomised clinical trial comparing the efficacy and tolerability of aceclofenac with diclofenac resinate in patients with acute low back pain. Clin Rheumatol 2003;22:127-35 (Pubitemid 36752631)
67. Szpalski M, Hayez JP. Objective functional assessment of the efficacy of tenoxicam in the treatment of acute low back pain. A double-blind placebo-controlled study. Br J Rheumatol 1994;33:74-8 (Pubitemid 24042042)
68. Ximenes A, Robles M, Sands G, et al. Valdecoxib is as efficacious as diclofenac in the treatment of acute low back pain. Clin J Pain 2007;23:244-50
69. Yakhno N, Guekht A, Skoromets A, et al. Analgesic efficacy and safety of lornoxicam quick-release formulation compared with diclofenac potassium: randomised, double-blind trial in acute low back pain. Clin Drug Investig 2006;26:267-77 (Pubitemid 43845692)
70. van Tulder MW, Scholten RJ, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group. Spine 2000;25:2501-13
71. Roelofs PD, Deyo RA, Koes BW, et al. Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine 2008;33:1766-74
72. See S, Ginzburg R. Choosing a skeletal muscle relaxant. Am Fam Physician 2008;78:365-70
73. Sakai Y, Matsuyama Y, Nakamura H, et al. The effect of muscle relaxant on the paraspinal muscle blood flow: a randomized controlled trial in patients with chronic low back pain. Spine 2008;33:581-7 (Pubitemid 351451718)
74. Englert R, Fontanesi G, Muller P, et al. Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain. Clin Ther 1996; 18:843-52 (Pubitemid 26397283)
75. Hancock MJ, Maher CG, Latimer J, et al. Assessment of diclofenac or spinal manipulative therapy, or both, in addition to recommended first-line treatment for acute low back pain: a randomised controlled trial. Lancet 2007; 370:1638-43 (Pubitemid 350052289)
76. Basmajian JV. Acute back pain and spasm. A controlled multicenter trial of combined analgesic and antispasm agents. Spine 1989;14:438-39
77. Childers MK, Borenstein D, Brown RL, et al. Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial. Curr Med Res Opin 2005;21:1485-93 (Pubitemid 41368582)
78. Chou R, Peterson K, Helfand M. Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage 2004;28:140-75 (Pubitemid 38970077)
79. Toth PP, Urtis J. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone. Clin Ther 2004;26:1355-67 (Pubitemid 39572151)
80. Chahl LA. Opioids - mechanisms of action. Aust Prescr 1996;19:63-5 (Pubitemid 26259471)
81. Kinkade S. Evaluation and treatment of acute low back pain. Am Fam Physician 2007;75:1181-8
82. Palangio M, Morris E, Doyle Jr. RT, et al. Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain. Clin Ther 2002; 24:87-99 (Pubitemid 34117526)
83. Reeves RR, Burke RS. Tramadol: basic pharmacology and emerging concepts. Drugs Today (Barc) 2008;44:827-36
84. Sarbu A, Radulescu F, Robertson S, et al. Onset of analgesic effect and plasma levels of controlled-release tramadol (Tramadol Contramid once-a-day) 200-mg tablets in patients with acute low back pain. J Opioid Manag 2008;4:285-92
85. Frerick H, Keitel W, Kuhn U, et al. Topical treatment of chronic low back pain with a capsicum plaster. Pain 2003;106:59-64 (Pubitemid 37329614)
86. Keitel W, Frerick H, Kuhn U, et al. Capsicum pain plaster in chronic non-specific low back pain. Arzneimittelforschung 2001;51:896-903 (Pubitemid 33096110)
87. Zimmerman J, Siguencia J, Tsvang E. Upper gastrointestinal hemorrhage associated with cutaneous application of diclofenac gel. Am J Gastroenterol 1995;90:2032-4
88. Voltaren Gel. United States prescribing information. Novartis. 2007. Available at: http://www.voltarengel.com/pdf/Voltaren-PI-10-19.pdf [Last accessed 9 May 2009]
89. Berenbaum F. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 2008;10(Suppl. 2):S1
90. Hunt RH, Choquette D, Craig BN, et al. Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs? Can Fam Physician 2007;53:1177-84 (Pubitemid 47236003)
91. Mitchell D. FDA panel recommends acetaminophen restriction, elimination of some prescription drugs, changes in OTC products possible. 2009. Available at: http://www.aafp.org/online/en/home/publications/news/news-now/clinical-care- research/20090702acetamin.html [Last accessed 3 May 2009]
92. Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol 2006;1:236-45
93. Chan FK, Graham DY. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications - review and recommendations based on risk assessment. Aliment Pharmacol Ther 2004; 19:1051-61 (Pubitemid 38703517)
94. Herná ndez-Díaz S, Rodríguez LA. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. Arch Intern Med 2000;160:2093-9 (Pubitemid 30482713)
95. Kellstein DE, Waksman JA, Furey SA, et al. The safety profile of nonprescription ibuprofen in multiple-dose use: a meta-analysis. J Clin Pharmacol 1999;39:520-32 (Pubitemid 29356474)
96. Lanza FL, Rack MF, Simon TJ, et al. Specific inhibition of cyclooxygenase-2 with MK-0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen. Aliment Pharmacol Ther 1999;13:761-7 (Pubitemid 29276845)
97. Fendrick AM, Greenberg BP. A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care 2009;3:1
98. Rahme E, Nedjar H. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rheumatology (Oxford) 2007;46:435-8 (Pubitemid 46344654)
99. Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation 2007;115:1634-42 (Pubitemid 46648649)
100. Lanza FL, Chan FK, Quigley EM, et al. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009;104:728-38
101. Khong E, Sim MG, Hulse G. Benzodiazepine dependence. Aust Fam Physician 2004;33:923-6
102. Schug SA. The role of tramadol in current treatment strategies for musculoskeletal pain. Ther Clin Risk Manag 2007;3:717-23 (Pubitemid 350162071)
103. Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl.):S105-20 (Pubitemid 351682081)
104. Martell BA, O'Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 2007;146:116-27 (Pubitemid 351640015)